Novo Nordisk expands Wegovy® $499-per-month offering to additional cash-paying patients via the Wegovy® savings offer

Core Points - Novo Nordisk is focused on developing innovative medicines and ensuring accessibility and affordability for communities, particularly through the Wegovy® savings program [1] - The Wegovy® savings program has been updated to offer a 28-day supply for cash-paying patients at $499, down from the previous$650 per month [2] - NovoCare® Pharmacy provides home delivery of Wegovy® prescriptions along with support services for patients [3] Summary by Category Company Commitment - Novo Nordisk emphasizes its commitment to innovation and accessibility in healthcare, particularly for obesity management through Wegovy® [1] - The company aims to empower individuals living with obesity to achieve their health goals [1] Wegovy® Savings Program - The updated Wegovy® savings offer allows cash-paying patients or those with non-covering insurance to access a 28-day supply for $499, a reduction from the previous$650 [2] - Patients with commercial insurance that covers Wegovy® may pay as little as $0 per month, with a maximum savings of$225 for a 28-day supply [2] NovoCare® Pharmacy Services - NovoCare® Pharmacy facilitates home delivery of Wegovy® prescriptions and offers additional support such as benefit verification and refill reminders [3] - The pharmacy aims to enhance patient experience and ensure they receive authentic, FDA-approved Wegovy® [1][3]